Evaluation of the economic impact of a national lymphoedema service in Wales

Lymphoedema Network Wales has focused on maximising the impact ofits service through the effective use of available resources to ensure highqualityand consistent care for people with lymphoedema across Wales. Theaim of this evaluation was to estimate the economic impact of a nationallymphoedema service on the NHS Wales budget. Work was undertaken todetermine the care pathway within Lymphoedema Network Wales and developa hypothetical ‘world without’ the service as a comparator. The four groupsof patients that made up the pathways were Group 0: ‘at risk’, Group 1-2:‘uncomplicated lymphoedema’, Group 3: ‘complicated/complex’ and Group4: ‘palliative care’. Overall resource utilisation between 6 months pre- and6 months post-entry indicated that there were significant cost reductions tobe seen after lymphoedema service entry for all patients in each group. Thisevaluation provides estimates that suggest that the service is likely to be costsaving when people with lymphoedema are managed within LymphoedemaNetwork Wales rather than in a ‘world without’ the service

Pneumatic compression devices for in-home management of lymphedema: two case reports

The two patients in this case series had experienced long-term difficulty controlling lymphedema at home. Both patients had used numerous home therapies, including older-generation intermittent pneumatic compression devices, without success. The Flexitouch® system, an advanced pneumatic device, was prescribed to assist them with in-home efforts by providing therapy to their affected limbs in addition to the lower trunk area for the patient with lymphedema of the lower extremity; and the trunk, chest wall, and shoulder areas for the patient with lymphedema of the upper extremity. Both patients achieved successful home maintenance of lymphedema, as judged by limb volume, clinical observations, and subjective patient impressions, after incorporating the Flexitouch® system. Neither patient experienced the deleterious effects (worsening genital edema; fibrotic cuff development) that they had experienced with the older-generation intermittent pneumatic compression devices they had previously used. Incorporating the Flexitouch® system as part of maintenance may improve success for lymphedema patients who have previously struggled with in-home management

Psychological Factors in chronic edema: a case–control study

Objective: To examine psychological health and perceived social support in patients with chronic oedema (CO). Methods: A random sample of patients who had been previously identified within a chronic oedema (CO) service in an urban area of south west London were group matched for age and gender with community controls in a case control study. Results: One hundred and seven cases and 102 controls (women 82%) were identified. CO was caused by cancer or its treatment in 51 (48%) of cases and affected the leg in 65 (61%); the arm 41(38%) and the limb and midline in 15 (14%). Length of time with CO was long with 50 (47%) suffering for > 10 years. Cases were more likely to be single or divorced/separated (p=0.041) and have reduced mobility (p <0.001). SF36 scores showed cases had significantly poorer overall HRQOL in particular: physical functioning (p=0.003); role physical (p <0.001) general health (p=0.026); vitality (p=0.015); social function (p=0.007) and role emotional (p=0.041). EQ5D health index scores were significantly reduced in cases by 13 points (P= <0.001, 95% CI 5.8, 21.6) compared with controls with a similar pattern for the VAS scale (p< 0.00 95% CI 7.6, 17.1). The MOS scale showed cases had similar size social networks to the control group (5.8/6.6 p=0.49) but had lower total perceived social support scores (67.8/76.1 p=0.018). Cases had reduced support in all 5 domains with tangible and affectionate support significantly reduced for cases compared to controls. Cases used significantly fewer coping strategies (COPE scale) than controls with regard to: active coping (p=0.024); planning (p<0.001) and use of instrumental support (p=0.006). Significantly higher levels of coping were used by cases for the following domains: restraint (p=0.031), positive reinterpretation and growth (p<0.001); acceptance (<0.001); denial (p<0.001); mental disengagement (p<0.001); 3 behavioural disengagement (<0.001): substance abuse (p=0.010) and humour (p<0.001). Conclusions: Patients with CO have poorer health and greater impact on many aspects of HRQOL. While the size of social networks they report appear preserved, the levels of perceived social support are reduced. The pattern of use of coping strategies was complex with evidence of reduced problem solving combined with enhanced emotion focused coping such as acceptance and reinterpretation indicating illness adjustment. Deficits in the ability to function socially combined with perceived reduction in support and reduced mental health and emotional scores within the SF36 scale indicate the risk of developing psychological issues such as depression. Systems of care should offer an environment to address these issues

Systematic Review of Magnetic Resonance Lymphangiography From a Technical Perspective

Background Clinical examination and lymphoscintigraphy are the current standard for investigating lymphatic function. Magnetic resonance imaging (MRI) facilitates three‐dimensional (3D), nonionizing imaging of the lymphatic vasculature, including functional assessments of lymphatic flow, and may improve diagnosis and treatment planning in disease states such as lymphedema. Purpose To summarize the role of MRI as a noninvasive technique to assess lymphatic drainage and highlight areas in need of further study. Study Type Systematic review. Population In October 2019, a systematic literature search (PubMed) was performed to identify articles on magnetic resonance lymphangiography (MRL). Field Strength/Sequence No field strength or sequence restrictions. Assessment Article quality assessment was conducted using a bespoke protocol, designed with heavy reliance on the National Institutes of Health quality assessment tool for case series studies and Downs and Blacks quality checklist for health care intervention studies. Statistical Tests The results of the original research articles are summarized. Results From 612 identified articles, 43 articles were included and their protocols and results summarized. Field strength was 1.5 or 3.0 T in all studies, with 25/43 (58%) employing 3.0 T imaging. Most commonly, imaging of the peripheries, upper and lower limbs including the pelvis (32/43, 74%), and the trunk (10/43, 23%) is performed, including two studies covering both regions. Imaging protocols were heterogenous; however, T2‐weighted and contrast‐enhanced T1‐weighted images are routinely acquired and demonstrate the lymphatic vasculature. Edema, vessel, quantity and morphology, and contrast uptake characteristics are commonly reported indicators of lymphatic dysfunction. Data Conclusion MRL is uniquely placed to yield large field of view, qualitative and quantitative, 3D imaging of the lymphatic vasculature. Despite study heterogeneity, consensus is emerging regarding MRL protocol design. MRL has the potential to dramatically improve understanding of the lymphatics and detect disease, but further optimization, and research into the influence of study protocol differences, is required before this is fully realized. Level of Evidence 2 Technical Efficacy Stage

LIMPRINT study - the Turkish experience

Background: Lymphedema and chronic oedema is a major healthcare problem in both developed and non-developed countries The LIMPRINT study is an international health service based study to determine the prevalence and functional impact in adult populations of member countries of the International Lymphoedema Framework (ILF). Methods: 1051 patients from 8 centers in Turkey were recruited using the LIMPRINT study protocol. Data were collected using the core and module tools which assess the demographic and clinical properties as well as disability and QoL. Results: Most of the Turkish patients were recruited from specialist lymphedema services and were found to be female, housewives and having secondary lymphedema due to cancer treatment. The duration of lymphedema was commonly less than 5 years and most of them had ISL Grade 2 lymphedema. Cellulitis, infection and wounds were uncommon. The majority of patients did not get any treatment or advice before. Most of the patients had impaired QoL and decreased functionality, but psychological support was neglected. Although most had social health security access to Lymphedema centres nevertheless access seemed difficult due to distance and cost. Conclusion: The study has shown the current status and characteristics of lymphedema patients, treatment conditions, the unmet need for the diagnosis and treatment as well as burden of the disease in both patients and families in Turkey. National health policies are needed for the prevention, diagnosis and treatment in Turkey that utilise this informative data

Four cornerstones of lymphoedema care

Lymphoedema is a progressive, debilitating condition caused by reduced or damaged lymphatic function. The condition can have a profound effect on individuals’ quality of life and wellbeing. Lymphoedema’s complex, enduring nature necessitates prevention wherever possible, early detection, self-management and integrated interventions based on the four cornerstones of care. Lymphoedema prevalence is increasing, particularly amongst older people. As the population of nursing and care home residents is ageing, lymphoedema prevention and management should be a serious concern for those working in nursing and residential care

Systematic review: conservative treatments for secondary lymphedema

<p>Abstract</p> <p>Background</p> <p>Several conservative (i.e., nonpharmacologic, nonsurgical) treatments exist for secondary lymphedema. The optimal treatment is unknown. We examined the effectiveness of conservative treatments for secondary lymphedema, as well as harms related to these treatments.</p> <p>Methods</p> <p>We searched MEDLINE^®, EMBASE^®, Cochrane Central Register of Controlled Trials^®, AMED, and CINAHL from 1990 to January 19, 2010. We obtained English- and non-English-language randomized controlled trials or observational studies (with comparison groups) that reported primary effectiveness data on conservative treatments for secondary lymphedema. For English-language studies, we extracted data in tabular form and summarized the tables descriptively. For non-English-language studies, we summarized the results descriptively and discussed similarities with the English-language studies.</p> <p>Results</p> <p>Thirty-six English-language and eight non-English-language studies were included in the review. Most of these studies involved upper-limb lymphedema secondary to breast cancer. Despite lymphedema's chronicity, lengths of follow-up in most studies were under 6 months. Many trial reports contained inadequate descriptions of randomization, blinding, and methods to assess harms. Most observational studies did not control for confounding. Many studies showed that active treatments reduced the size of lymphatic limbs, although extensive between-study heterogeneity in areas such as treatment comparisons and protocols, and outcome measures, prevented us from assessing whether any one treatment was superior. This heterogeneity also precluded us from statistically pooling results. Harms were rare (< 1% incidence) and mostly minor (e.g., headache, arm pain).</p> <p>Conclusions</p> <p>The literature contains no evidence to suggest the most effective treatment for secondary lymphedema. Harms are few and unlikely to cause major clinical problems.</p